While previous epidemiological studies report adverse effects of long-term noise exposure on cardiovascular health, the mechanisms responsible for these effects are unclear. We sought to elucidate the cardiovascular and stress response to short-term, low (31.5-125 Hz) and high (500 – 2000 Hz) frequency noise exposures.
Healthy male (n = 10) participants were monitored on multiple visits during no noise, low- or high-frequency noise exposure scenarios lasting 40 minutes. Participants were fitted with an ambulatory electrocardiogram (ECG) and blood pressure measures and saliva samples were taken before, during and after noise exposures. ECGs were processed for measures of heart rate variability (HRV): high-frequency power (HF), low-frequency power (LF), the root of the mean squared difference between adjacent normal heart beats (N-N) intervals (RMSSD), and the standard deviation of N-N intervals (SDNN). Systolic blood pressure (SBP), diastolic blood pressure (DPB), and pulse were reported and saliva was analyzed for salivary cortisol and amylase. Multivariate mixed-effects linear regression models adjusted for age were used to identify statistically significant difference in outcomes by no noise, during noise or after noise exposure periods and whether this differed by noise frequency.
A total of 658, 205, and 122, HRV, saliva,and blood pressure measurements were performed over 41 person days. Reductions in HRV (LF and RMSSD) were observed during noise exposure (a reduction of 19%(−35,−3.5) and 9.1%(−17,−1.1), respectively). After adjusting for noise frequency, during low frequency noise exposure, HF, LF, and SDNN were reduced (a reduction of 32%(−57,−6.2), 34%(−52,−15), and 16%(−26,−6.1), respectively and during high frequency noise exposure, a 21%(−39,−2.3) reduction in LF, as compared to during no noise exposure was found. No significant (p>0.05) changes in blood pressure,salivary cortisol or amylase were observed.
These results suggest that exposure to noise, and in particular, to low-frequency noise negatively impacts HRV. The frequencies of noise should be considered when evaluating the cardiovascular health impacts of exposure.
Noise, defined as unwanted sound, is a ubiquitous environmental and occupational stressor. While noise is quite common, it is a complex exposure due to its varying subjective (annoyance and sensitivity) and objective (loudness, frequency/pitch) characteristics. The effects of noise on hearing are well elucidated. However, in recent years particular interest has been in parsing out its effects on cardiovascular health. Associations of
It is hypothesized that noise affects cardiovascular health through a stress mechanism via the autonomic nervous system and endocrine system. Over short time periods, noise exposed individuals experience increases in blood pressure, changes in heart rate variability (HRV), and the secretion of stress hormones including cortisol and amylase (
In experimental studies, the stress mechanism hypothesis has been tested using short-term exposure to noise and biological stress response measures of blood pressure, HRV, salivary amylase, and cortisol. Results of such studies are mixed. For blood pressure, while
One of the major limitations of mechanistic studies of noise and stress is their implicit assumption that the sound pressure level is the most relevant characteristic. What is less known, however, is the influence of noise frequency on the stress response. The importance of considering noise frequency comes primarily from laboratory studies. These types of studies suggest that our body's organs respond to different frequencies differentially, with low-frequency noise being especially deleterious (
We conducted a pilot study to investigate: (1) whether noise exposure produced acute changes in stress and cardiovascular responses; and (2) whether these responses differed based on noise frequency. Using a panel study design where participants were monitored on multiple visits during no noise, low- or high-frequency noise exposure scenarios, we evaluated changes of cardiac autonomic function as measured by HRV and blood pressure and on the endocrine system as measured by salivary cortisol and amylase.
Between May and June of 2012, study participants were recruited to participate in this pilot study using a flyer placed in common areas of the UConn Health campus, a broadcast on a television screen within the UConn Health cafeteria as well as through a broadcast email message sent to UConn Health employees and staff. Upon scheduling of the study visit, the potential participants were screened to determine eligibility (male, 18-40 years old, no known hearing loss, and free from treated high blood pressure, known heart disease including irregular rhythm, heart failure, heart surgery, and history of heart attack). Participants were instructed to refrain from eating and drinking (water excluded) and from listening to loud music in the car or via headphones for 2.5 hours prior to all subsequent study visits.
At the first visit, prior to beginning the study protocol, study participants gave informed consent and completed a standard audiometric screening to confirm normal hearing. Persons with pure-tone, air conduction hearing threshold levels determined by audiometry at frequencies from 125 to 8000 Hz of 20 dB hearing level or more were ineligible. The first visit lasted approximately 3 hours due to the audiometric testing. The remaining visits lasted approximately 2 hours each. All study methods were approved by UConn Health's and Harvard T.H. Chan School of Public Health's Institutional Review Boards.
The study was performed in a reverberation room within the UConn Health Acoustics Laboratory. Study enrollees were asked to participate in up to five visits, during which they experienced different noise exposure scenarios including either:1) no noise exposure (up to one visit); 2) low-frequency noise exposure (up to two visits); or 3) high-frequency noise exposure (up to two visits). The order of the scenarios was randomly administered with at least one day between scenarios. Individuals were scheduled during the same time of day, within an hour, for each session to control for natural circadian rhythm.
The study protocol for each visit is presented in
Loudspeakers were positioned within the reverberation room at a standardized location for each participant and provided high- or low-frequency noise as needed. For the “low-frequency” scenario, the noise exposure was a low-frequency noise dominated by sound in the frequency range from 31.5 to 125 Hz with an overall sound level of 75 dB(A). For the “high-frequency” scenario, the noise exposure was dominated by sound in the frequency range from 500 Hz to 2 kHz at 75 dB(A). This sound level was chosen to avoid noise-induced changes in hearing threshold (Miller, 1974). For “no noise” exposure and periods of time before noise exposure, the average sound level in the reverberation room was 50 dB(A) (i.e., the background noise). During each scenario, noise levels and frequencies were monitored with a calibrated sound level meter (Bruel and Kjaer, type 2260).
To measure HRV, participants were outfitted with a standard 5-lead ambulatory GE SEER Light ECG Holter monitor that was worn for the duration of the experiment. Recordings were analyzed in the time and frequency domains for HRV by the Cardiovascular Epidemiology Group of Beth Israel Hospital, Boston, MA. Trained technicians, blinded to exposure, used standard criteria to identify and label all normal or abnormal beats. For the purposes of our analysis, HRV was summarized using the frequency domain measures of high-frequency power (0.15 – 0.40 Hz) (HF), primarily reflecting the activity the parasympathetic nervous system (PNS), and low-frequency power (0.04 - 0.15 Hz) (LF), reflecting the activity of both the sympathetic (SNS) and PNS. The time domain measures used included RMSSD, the root of the mean squared difference between adjacent normal heart beats (N-N) intervals, which represents a measure of overall degree of HRV and SDNN, the standard deviation of N-N intervals, which measures total heart rate variability (
Systolic and diastolic blood pressure (SBP and DBP, respectively), as well as pulse measurements were taken using a standard blood pressure monitor at three times during the course of the experiment: at the end of the initial 20 minute “no noise” period immediately before the noise exposure scenario commenced, immediately after the noise exposure scenario, and at the end of the “after noise” period (
Heart rate variability data were averaged over five minutes to ensure a uniform time series. Three exposure periods were considered for our analysis: (1) ‘No Noise’, which included the baseline scenario as well as before any noise exposure commenced during the low- or high-frequency exposure scenario; (2) ‘During Noise’, which included the time during the low- or high-frequency noise exposure scenarios; and (3) ‘After Noise’, which included the time after the low- or high-frequency noise exposure study periods. Descriptive statistics (geometric mean, standard deviation, minimum, maximum, range) were calculated for all health measures. We estimated mean levels and 95% confidence intervals (CIs) of salivary amylase and cortisol, blood pressure (SBP, DPB, and pulse) and HRV (HF, LF, RMSSD, SDNN) using mixed models, which accounted for the correlation of repeated measures within persons. An autoregressive covariance matrix was chosen as it was shown to minimize Akaike's information criterion.
The specification for both models is:
Response variables were log-transformed to ensure normally-distributed residuals. Residual plots were assessed to check the normality of the residuals and fit of the model. All analyses were conducted using SAS (version 9.4; SAS Institute Inc., Cary, N.C.).
Overall, we had a total of 13 study participants. However, three participants were excluded in our analysis—one for of violating study protocol and two because they only completed a “no noise” noise exposure. The mean age was 26 years, with a standard deviation of approximately 8 years. Of the 10 participants, 9 participated in the “no noise” exposure scenario, 7 in at least one of the low-frequency scenarios, and 9 in at least one of the high-frequency scenarios. Six participants completed all six sessions and 7 completed at least one of each of the exposure scenarios for a total of 41 person-days of monitoring. We obtained a total of 658, 181, and 81, HRV, saliva, and blood pressure measurements, respectively.
Descriptive statistics of these biological measurements throughout the course of the experiment are presented in
The results from linear mixed
In
For salivary amylase, declines were observed during low-frequency noise exposure while increases were observed during high-frequency noise exposure. However, neither of these effects were statistically significant. In contrast, there were small increases in cortisol during both low- and high-frequency noise exposures. After the noise exposure ended, there were further non statistically significant changes in levels of both amylase and cortisol.
Finally, for blood pressure, after both low- and high-frequency noise exposures, diastolic blood pressure increased while the systolic blood pressure appeared less affected and the pulse rate decreased. None of these effects were statistically significant.
The main purpose for this study was to test whether noise exposure produced acute changes in stress and cardiovascular responses and whether these responses differed based on noise frequency operating under the hypothesis that noise acts on the body as physiological stressor. This stressor disrupts homeostasis by dysregulating the hypothalamic-pituitary-adrenocortical (HPA) and sympathetic-adrenal-medullar (SAM) axis by prolonging typical “fight or flight” responses such as increases in blood pressure or the secretion of cortisol (
Studies able to capture HRV activity during noise exposure tend to be consistent with our findings. For concurrent noise exposures,
Contrary to our results,
Similar to our findings of non-statistically significant increases in blood pressure after exposure to low-frequency noise,
For salivary amylase and cortisol,
Contrasting results between our study and others can most likely be attributed, at least in part, to differences in study design—in particular, differences in how the noise exposure was defined and differences in the time periods in which the cardiovascular and stress measures were analyzed. Noise exposures in all studies were different in terms of intensity, frequency profile, duration and context.
Further, differences in when cardiovascular and stress measures were analyzed may also contribute to differences in observed responses to noise exposure. We had three distinct exposure time periods—no noise, during noise, and after noise. Our results were most consistent with those who examined responses during similar time frames.
Study population differences may also explain contrasting results. Our study only included healthy, young males. The cardiovascular response to noise may differ by gender. While no gender effect was observed by
Some limitations of our findings should be considered. First, the number of study participants was small and while we observed some statistically significant cardiovascular responses to noise, such a small sample size may have limited our ability to detect all cardiovascular responses to noise. While we considered healthy males, we did not collect information on existing stress and sensitivity to noise. Previous research suggests that sensitivity plays a significant role in how individuals biologically respond to noise exposure (
From our results, we know that there is a statistically significant decline in HRV with low-frequency noise exposure. How this relates to clinical outcomes is unclear. We did observe recuperation of negative dips in HRV after the noise exposure ended. Acutely, effects include typical fight or flight reactions such as increased blood pressure and cardiac output while indirect effects include hormone release (
And while our sample size was quite small, our study design allowed each individual to serve as his own control, thereby enabling the examination of individual differences. We were also able to focus on the effect of noise frequency, which eliminates bias that may be introduced by known environmental noise sources. The study is also one of only a few that has looked at the effects of audible noise frequencies on such a wide variety of stress and cardiovascular outcomes.
In conclusion, the study adds to our understanding of the acoustic characteristic that drives the cardiovascular autonomic response to noise exposure. The results suggest that low-frequency noise in particular negatively impacts heart rate variability and these impacts may persist after noise exposure ends. In future studies, the dominant frequencies of noise should be considered when evaluating the cardiovascular health effects of noise.
We would like to thank Jinming Zhang, Eric Bernstein, and Gongqiang Yu for assistance with performing the study and Jennifer Garza for manuscript review.
Approval for Human Subjects Research
This study was approved by both the UConn Health and Harvard T.H. Chan School of Public Health Institutional Review Boards.
Funding sources
This investigation was made possible by Grant No. 2 T42 OH008416-07, from the National Institute for Occupational Safety and Health (NIOSH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIOSH. Erica Walker was supported by a NIH Pre-Doctoral Environmental Epidemiology Training Grant T32ES007069.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Study Protocol and Sampling Scheme
| Time Period | Acclimation (10 min) | Before (10 min) | During (40 min) | After (30 min) | ||||
|---|---|---|---|---|---|---|---|---|
| Noise Exposure Scenarios | ||||||||
| Background 50 dB(A) | No Noise | No Noise | No Noise | No Noise | ||||
| High Frequency 75 dB(A) | No Noise | No Noise | During Noise | After Noise | ||||
| Low Frequency 75 dB(A) | No Noise | No Noise | During Noise | After Noise | ||||
Biological Sampling | ||||||||
| ECG Monitor | X | X | X | X | X | X | X | |
| Blood Pressure | X | X | ||||||
| Saliva | X | X | X | X | X | |||
Statistical analysis was performed by considering three exposure periods (no noise, during noise, and after noise)
Descriptive Statistics of HRV, Saliva, and Blood Pressure Parameters by Exposure Period
| No Noise | During Noise | After Noise | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GM | GSD | Min | Max | Range | GM | GSD | Min | Max | Range | GM | GSD | Min | Max | Range | |
| HRV Parameters | n = 233 | n = 244 | n = 181 | ||||||||||||
| LF (msec2) | 1999 | 59.1 | 199 | 12390 | 12191 | 1835 | 95.3 | 237 | 14489 | 14252 | 1839 | 82.9 | 426 | 13458 | 13033 |
| HF (msec2) | 1070 | 49.3 | 33.1 | 9293 | 9260 | 920 | 77.3 | 54.4 | 11119 | 11064 | 989 | 69.7 | 90.3 | 10707 | 10617 |
| RMSSD (msec) | 45.9 | 0.96 | 10.2 | 138 | 128 | 42.7 | 1.64 | 13.5 | 122 | 109 | 44.7 | 1.44 | 17.1 | 136 | 119 |
| SDNN (msec) | 87.6 | 1.31 | 26.1 | 207 | 181 | 82.5 | 2.24 | 28.7 | 200 | 172 | 84.1 | 1.83 | 40.1 | 201 | 161 |
| Saliva Parameters | n = 81 | n = 31 | n = 93 | ||||||||||||
| Amylase (U/ml) | 96.1 | 7.8 | 9.5 | 342 | 332 | 86.1 | 9.6 | 15.7 | 190 | 174 | 105 | 7.7 | 20.0 | 344 | 324 |
| Cortisol (U/dl) | 0.13 | 0.008 | 0.03 | 0.50 | 0.47 | 0.13 | 0.01 | 0.04 | 0.34 | 0.30 | 0.12 | 0.01 | 0.04 | 2.71 | 2.67 |
| Blood Pressure | n = 61 | n = 0 | n = 61 | ||||||||||||
| Diastolic (mm Hg) | 73.5 | 0.91 | 53.5 | 103 | 49.0 |
| 75.5 | 0.93 | 60.0 | 99.0 | 39.0 | ||||
| Systolic (mm Hg) | 114 | 1.21 | 99.5 | 143 | 43.0 |
| 113 | 1.07 | 99.0 | 135 | 36.0 | ||||
| Pulse (bpm) | 64.0 | 1.29 | 47.5 | 86.5 | 39.0 |
| 60.6 | 1.31 | 48.5 | 85.5 | 37.0 | ||||
Blood pressure measurements were not taken during the noise exposure period
Percent Change (95% CI) in Stress and Cardiovascular Response by Exposure Period and Noise Frequency
| Model 1 | Model 2 | |||||
|---|---|---|---|---|---|---|
| Low Frequency | High Frequency | |||||
| HRV Parameters B(95% CI) | During Noise | After Noise | During Noise | After Noise | During Noise | After Noise |
| HF | −11 (−31, 8.6) | 32 (12, 52) | −32 (−57, −6.2) | 18 (−8.1, 43) | −8.8 (−34, 16) | 28 (2.9, 53) |
| LF | −19 (−35, −3.5) | 16 (−0.2, 31) | −34 (−52, −15) | 2.4 (−17, 22) | −21 (−39, −2.3) | 12 (−6.4, 31) |
| RMSSD | −3.4 (−13, 5.7) | 15 (5.3, 24) | −12 (−24, 0.7) | 7.4 (−5.0, 20) | −4.1 (−16, 7.9) | 13 (0.8, 25) |
| SDNN | −9.1 (−17, −1.1) | 9.7 (1.6, 18) | −16 (−26, −6.1) | 4.7 (−5.3, 15) | −8.1 (−18, 1.6) | 9.2 (−0.6, 19) |
|
| ||||||
| Amylase | −1.6 (−20, 16) | 19 (4.4, 33) | −3.7 (−38, 31) | 19 (−12, 50) | 5.3 (−29, 39) | 23 (−7.3, 53) |
| Cortisol | −8.0 (−24, 8.1) | −14 (−27, −1.1) | 6.4 (−31, 44) | −16 (−51, 19) | 12 (−25, 49) | 21 (−14, 56) |
|
| ||||||
| Diastolic Blood Pressure | −3.5 (−5.7, −1.2) | −0.9 (−5.2, 3.4) | −3.2 (−7.4, 1.0) | |||
| Systolic Blood Pressure | −0.3 (−2.1, 1.5) | −0.9 (−4.8, 3.0) | −0.8 (−4.6, 3.0) | |||
| Pulse | 7.7 (5.0, 10) | 5.4 (−0.7, 11) | 2.4 (−3.6, 8.3) | |||
All models are adjusted for age; Reference category is no noise.
denotes statistical significance (p-value 0.05)
In a repeated measures laboratory study of healthy males (n = 10), the acute effects of exposures to low and high frequency noise on changes in cardiovascular and stress responses was investigated.
Reductions in HRV (LF and RMSSD) were observed during noise exposure (a reduction of 19% (−0.35, −0.03) and 9% (−0.17, −0.01), respectively). After adjusting for noise frequency, during low frequency noise exposure, HF, LF, and SDNN were reduced (a reduction of 0.32% (−0.57, −0.06), 0.34% (−0.52, −0.15), and 0.16% (−0.26, −0.06), respectively and during high frequency noise exposure, a 21% (−0.39, −0.02) reduction in LF, as compared to during no noise exposure, was found.
No significant (p<0.05) changes in blood pressure, salivary cortisol, or amylase were observed.